MARKET RADAR
SENSEX     NIFTY      
Moneycontrol.com India | Notes to Account > Pharmaceuticals > Notes to Account from Torrent Pharmaceuticals - BSE: 500420, NSE: TORNTPHARM
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > NOTES TO ACCOUNTS - Torrent Pharmaceuticals
Torrent Pharmaceuticals
BSE: 500420|NSE: TORNTPHARM|ISIN: INE685A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
  
LIVE
BSE
Feb 10, 17:00
571.30
6.9 (1.22%)
VOLUME 296,003
LIVE
NSE
Feb 10, 17:00
563.65
-1.35 (-0.24%)
VOLUME 301,782
Explore Torrent Pharma connections « Mar 10
Notes to Accounts Year End : Mar '11
(Rs. in lacs)
                                               As at            As at
                                             31-Mar-2011    31-Mar-2010
 
 1.  Contingent Liabilities not provided 
 for in respect of :
 
 (a) Claims against the Company not 
 acknowledged as debts Disputed Demand of 
 Income Tax for which appeals have been 
 preferred                                       153.17         227.66
 
 Disputed Employee State Insurance 
 Contribution Liability under E.S.I. Act, 1948   390.98         287.54
 
 Disputed Legal cases for supply of
 Goods and Services                                1.78         122.90
 
 Disputed Demand of Excise and Service Tax        72.16          30.31
 
 Disputed Demand of Local Sales Tax and C.S.T.    65.32          70.56
 
 Disputed cases at Labour Court / Industrial 
 Court                                            92.67          62.36
 
                                                 776.08         801.33
 
 2. Excise Duty shown as deduction from Domestic Sales represents the
 amount of excise duty collected on sales. Excise duty expenses under
 Schedule - 18, Manufacturing and Other Expenses, represents the
 difference between excise duty element in closing stocks and opening
 stocks, excise duty paid on samples and on inventory write-off, which
 is not recoverable from sales.
 
 (b) The Government Grant income during the year represents grant
 received from the Department of Biotechnology for development of
 Diiodothyronine (T2) analogue, a New Chemical Entities [NCE] project.
 
 (c) Depreciation and Amortisation includes Rs. 1,670.31 lacs (previous
 year Rs. 1,919.90 lacs) pertaining to Research and Development assets.
 
 3.  Sundry Debtors in Schedule - 8 include debts due from Torrent Power
 Limited, a company under the same management as per section 370(1B) of
 the Companies Act, 1956 amounting to Rs. 2.39 lacs (previous year Rs. Nil).
 
 (b) Other than above, the Company has not given any loans or advances
 in the nature of loan to any of its subsidiaries and associates or fi
 rms / companies, in which Directors are interested.
 
 (c) There are no loans where either repayment schedule is not
 prescribed or repayment is scheduled beyond seven years.
 
 (d) Loan given to Zao Torrent Pharma, a wholly owned subsidiary, is at
 nil interest rate. There are no other loans where either no interest is
 charged or interest is below the rate specifi ed in section 372A of the
 Companies Act, 1956.
 
 4. The accruing liability on account of gratuity (retirement benefit
 in the nature of defi ned benefits plan) is accounted as per
 Accounting Standard 15 (revised 2005) Employee Benefits.
 
 General Description of the Plan :
 
 The Company operates a defi ned benefit plan (the Gratuity Plan)
 covering eligible employees, which provides a lump sum payment to
 vested employees at retirement, death, incapacitation or termination of
 employment, of an amount based on the respective employees salary and
 the tenure of employment.
 
 
 
 
 
 
 
Source : Dion Global Solutions Limited
Quick Links for torrentpharmaceuticals
Follow moneycontrol.com

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.